Antibiotics Market Size

  • Report ID: 4465
  • Published Date: May 08, 2025
  • Report Format: PDF, PPT

Antibiotics Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037

Antibiotics Market in 2025 is assessed at USD 53.95 billion. The global Market size was valued at over USD 50.55 billion in 2024 and is expected to expand at a CAGR of around 8.4%, surpassing USD 144.25 billion revenue by 2037. Asia Pacific is forecast to exceed majority share by 2037, driven by growing prevalence of infectious diseases, increasing antibiotic consumption, and a rapidly growing population.

The growth of the market is primarily attributed to the worldwide growing prevalence of various communicable diseases, such as TB, HIV, and others. As per the World Health Organization (WHO) statistics, in 2020, an estimated 1.5 million (UI 1.0 to 2.0 million) people were infected with HIV for the first time. This brought the global HIV population to 38.4 million people by 2021.

Antibiotics are antibacterial compounds that are active against bacteria. It is the most common type of antibacterial agent used to treat bacterial infections. Antibiotic medications are commonly used to treat and prevent such infections. They either kill or inhibit bacterial growth. Such factor is leading up the growing consumption of various types of antibiotics across the globe. For instance, global antibiotic consumption rates surged by 47% between 2000 and 2018 (from 9.8 to 14.3 defined daily doses (DDD) per 1000 people per day).


Antibiotics Market

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Antibiotics Market in 2025 is assessed at USD 53.95 billion.

The global market size was valued at over USD 50.55 billion in 2024 and is expected to expand at a CAGR of around 8.4%, surpassing USD 144.25 billion revenue by 2037.

Asia Pacific is forecast to exceed majority share by 2037, driven by growing prevalence of infectious diseases, increasing antibiotic consumption, and a rapidly growing population.

The major players in the market include F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bristol-Myers Squibb Company, Teva Pharmaceuticals Industries Ltd., Pfizer Inc., Abbott Laboratories, Merck & Co., Inc., Lupin Limited, Melinta Therapeutics, LLC, Bayer AG.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos